Page last updated: 2024-08-24

tenidap and Carcinoma, Hepatocellular

tenidap has been researched along with Carcinoma, Hepatocellular in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gabel, CA; Laliberte, RE; McNiff, PA; Pazoles, CJ; Svensson, L	1

Other Studies

1 other study(ies) available for tenidap and Carcinoma, Hepatocellular

Article	Year
Inhibition of cytokine activation processes in vitro by tenidap, a novel anti-inflammatory agent. Cytokine, 1995, Volume: 7, Issue:2 Topics: Anti-Inflammatory Agents, Non-Steroidal; Carcinoma, Hepatocellular; Cell Line; Cells, Cultured; Cycloheximide; Dose-Response Relationship, Drug; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Indoles; Interleukin-1; Interleukin-6; Lipopolysaccharides; Liver Neoplasms; Monocytes; Oxindoles; Protein Biosynthesis; Tumor Cells, Cultured	1995

Article

Year

Inhibition of cytokine activation processes in vitro by tenidap, a novel anti-inflammatory agent.

Cytokine, 1995, Volume: 7, Issue:2

Topics: Anti-Inflammatory Agents, Non-Steroidal; Carcinoma, Hepatocellular; Cell Line; Cells, Cultured; Cycloheximide; Dose-Response Relationship, Drug; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Indoles; Interleukin-1; Interleukin-6; Lipopolysaccharides; Liver Neoplasms; Monocytes; Oxindoles; Protein Biosynthesis; Tumor Cells, Cultured

1995